About Impetis Biosciences Limited
Data last updated:
Impetis Biosciences Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Tata Sons Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PLC295474. Its GSTIN is 27AAECI5150L1ZE (Maharashtra).
The company has an authorised share capital of ₹4.9 Cr and a paid-up capital of ₹3.73 Cr. It is led by directors including Tarun Dayal Bhojwani and Abhishek Jain.
Its last annual general meeting (AGM) was held on 09 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.48 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹85,575 (net margin 0.6%) and EBITDA of ₹1.16 Cr (EBITDA margin 78.4%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 26% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Impetis. The company has 1 deal on record (1 acquisition); the latest was in July 2017.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impetisbiosciences.com.
Company details
Contact details
Impetis Biosciences Limited's registered office is in Mumbai, Maharashtra. Its website is impetisbiosciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address6th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Impetis Biosciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Impetis Biosciences operates one associated brand: Impetis. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drug discovery and licensing for auto-immune, inflammatory, and oncology treatments via partnerships. | impetisbiosciences.com |
Business activity
The main business activity of Impetis Biosciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Impetis Biosciences Limited, buy the company report.
Financials of Impetis Biosciences Limited
FY 2026 filings availableImpetis Biosciences Limited reported revenue of ₹1.48 Cr (down 8% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 8% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹85,575 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 78.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Impetis Biosciences Limited, buy the company report.
Board of directors of Impetis Biosciences Limited
Impetis Biosciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Dayal Bhojwani Also directs: Tata Industries Limited, Enlearning Skill Development Limited, Tata Classedge Limited and 1 more | Director | 16 Jan 2025 | 1 Years 9 Months | Current |
| Abhishek Jain | Director | 04 Mar 2024 | 2 Years 7 Months | Current |
| Shaurya Nemish Mehta | Additional Director | 29 Jun 2026 | 0 Years 4 Months | Current |
Auditor
Impetis Biosciences Limited is audited by M. A. PARIKH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. A. PARIKH & CO. | FY 2023 | 107556W |
Shareholding
The shareholding of Impetis Biosciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Impetis Biosciences Limited, buy the company report.
Deals & funding
Impetis Biosciences Limited has 1 deal on record (1 acquisition); the latest was in July 2017.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2017 | Acquisition | ₹3.48 Cr | Buyer: Rallis India Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Impetis Biosciences Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Impetis Biosciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Impetis Biosciences Limited has a workforce of 2 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Impetis Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI5150L1ZE | Maharashtra | Active | 15 Aug 2017 |
To see the full GST registrations and return filing status of Impetis Biosciences Limited, buy the company report.
Recent activity
Impetis Biosciences Limited has 10 board changes on record since 2019: 4 appointments and 6 cessations. The latest: Shaurya Nemish Mehta was appointed as Additional Director on 29 Jun 2026.
1 earlier event is in the company report.
Frequently asked questions
Impetis Biosciences is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PLC295474.
Impetis Biosciences has 3 current directors:
- Tarun Dayal Bhojwani - Director
- Abhishek Jain - Director
- Shaurya Nemish Mehta - Additional Director
The latest financial statements of Impetis Biosciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 09 June 2026. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Impetis Biosciences is 27AAECI5150L1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Impetis Biosciences is U74999MH2017PLC295474. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Impetis Biosciences was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Impetis Biosciences has 1 deal on record (1 acquisition); the latest was in July 2017.
Shaurya Nemish Mehta was appointed as Additional Director on 29 Jun 2026. Attreyi Mukherjee ceased to be Director on 30 Sep 2025. Tarun Dayal Bhojwani ceased to be Additional Director on 23 Jun 2025. Impetis Biosciences has 10 board changes on record in total.
Impetis Biosciences can be reached through the website impetisbiosciences.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Impetis Biosciences is at 6th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
